Fenretinide is a synthetic retinoid derivative primarily investigated as a chemopreventive agent for prostate cancer and to reduce the risk of contralateral breast cancer in women at high risk. This category… Read more
Fenretinide is a synthetic retinoid derivative primarily investigated as a chemopreventive agent for prostate cancer and to reduce the risk of contralateral breast cancer in women at high risk. This category features high-quality reference standards essential for the pharmaceutical analysis of this compound, including the active pharmaceutical ingredient, known pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. Laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control protocols. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for accurate quantification in complex matrices, such as during pharmacokinetic studies. By providing access to these precise standards, such as glucuronide metabolites and specific derivatives like hydroxy or methoxy variants, researchers can ensure the accuracy and reliability of their analytical methods throughout the drug development and manufacturing lifecycle.